Company intelligence / Profile preview

Qt

Novato, California, United Statesqt.io ↗

Ownership: Private
Development stage: Other

Overview

QT Imaging Holdings has developed and commercialized the QT Breast Acoustic CT™ System, an FDA-cleared medical imaging device that uses low-frequency sound waves for 3D body and breast imaging. The company shipped six systems in Q1 2025 for $2.7 million in revenue. Their technology aims to provide safe, affordable, accessible diagnostic solutions with a focus on improving patient experience.

Therapeutic areas: OtherWomen's Health
Modalities: Device
Industry: Medical Imaging

Partnerships

NXC Imaging

Beyond the preview

Go deeper on Qt.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qt.

Explore the full profile